Metastatic Unresectable Gastrointestinal Stromal Tumors (GIST) Study

Novartis Clinical Trials and Medical Research Studies Recruiting in the U.S.

Mailing List


	Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only.

Novartis Clinical Trials provides information about research studies recruiting within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S.

Study Description

Screening

Study Centers

Contact/Consent

Metastatic Unresectable Gastrointestinal Stromal Tumors (GIST) Study - G2301

A randomized, open-label, multi-center phase III study to evaluate the efficacy and safety of a Novartis investigational drug versus an approved therapy in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST). An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.
Trial phase: Phase 3
Participation Duration: Participants enrolling in this study will be required to visit the study center 4 times within the first month. Follow up visits will be required every 3 months until the trial is complete (up to 10 years).
Protocol Number: CAMN107G2301

The next step is to see if you (or the participant) meet the basic criteria required for participation in this clinical trial. Please fill out the questionnaire below to see if you (or the participant) may be suitable for the clinical trial. Your answers to these questions are not retained by this system. You must answer the questions below for yourself, or, you must be the legally authorized representative of the potential participant in order to answer the questions on their behalf. If you (or the participant) do not meet the preliminary qualifications, you may search for other clinical trials of interest or sign up to the Mailing List.

Answers to all questions are required to determine if you meet the preliminary qualifications for the study.

1) Participation in a clinical trial will require travel to a study center where the clinical trial is being conducted. How far would you (or the participant) be willing to travel to a study center to participate in this clinical trial? Please note that participation in these clinical trials may require a number of visits to the study center and travel expenses may not be covered.

25 miles 50 miles 100 miles 150 miles Unlimited

2) Please enter your residential postal zip code.

	Site Map \| Contact Us \| Find a Clinical Trial \| Mailing List \| Clinical Trial FAQs
	Clinical Trials Glossary \| About Informed Consent \| Medical Research Areas
	Clinical Trial Resources \| How to use this website